BRIEF published on 10/29/2025 at 17:50, 1 month 6 days ago IntegraGen : Résultats en Baisse, Réduction des Dépenses au 1er Semestre 2025 Résultats Financiers Trésorerie Génomique Réduction Coûts Certification CLIA/CAP
BRIEF published on 10/29/2025 at 17:50, 1 month 6 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
PRESS RELEASE published on 10/29/2025 at 17:45, 1 month 6 days ago Informations privilégiées / Communiqué sur comptes, résultats IntegraGen annonce une baisse de 20% des charges d’exploitation et une trésorerie de 1,7 M€ au 30 juin 2025. L'accent est mis sur l'exécution opérationnelle et le développement des activités cliniques/pharma Développement Trésorerie IntegraGen Certification CLIA/CAP Baisses Charges
BRIEF published on 07/02/2025 at 07:35, 5 months 2 days ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
BRIEF published on 07/02/2025 at 07:35, 5 months 2 days ago IntegraGen signale une baisse de ses ventes et de ses réserves de trésorerie Baisse Des Ventes Coûts Opérationnels IntegraGen Besoins De Financement Analyses Génomiques
PRESS RELEASE published on 07/02/2025 at 07:30, 5 months 2 days ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
PRESS RELEASE published on 07/02/2025 at 07:30, 5 months 2 days ago Informations privilégiées / Autres communiqués Communiqué de presse: Chiffre d’affaires de 2,5 M€ et trésorerie de 2,1 M€ au premier semestre 2025 pour IntegraGen. Baisse des activités et exploration stratégique pour assurer la continuité des opérations Chiffre D'affaires Stratégie Baisse Trésorerie IntegraGen
BRIEF published on 01/15/2025 at 18:49, 10 months 20 days ago Chiffre d'affaires d'IntegraGen en baisse pour 2024 Chiffre D'affaires Croissance Trésorerie Génomique SeqOIA
BRIEF published on 01/15/2025 at 18:49, 10 months 20 days ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
PRESS RELEASE published on 01/15/2025 at 18:44, 10 months 20 days ago Informations privilégiées / Information sur chiffre d’affaires annuel IntegraGen annonce un chiffre d'affaires annuel de 8,5 M€ pour 2024, en baisse de 27%, et une trésorerie de 1,9 M€. Perspectives de croissance positives malgré la baisse due à l'arrêt de SeqOIA Chiffre D'affaires Croissance Baisse Trésorerie IntegraGen
Published on 12/05/2025 at 02:35, 4 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 25 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 11 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
